Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Hepatitis C

Free Subscription Articles published in J Hepatol Retrieve available abstracts of 168 articles: HTML format

Single Articles

May 2009
1. BARTOSCH B , Thimme R, Blum HE, Zoulim F, et al
   Hepatitis C virus-induced hepatocarcinogenesis.
   J Hepatol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
2. PFEFFER S , Baumert TF
   Unravelling the importance of microRNAs during hepatitis C virus infection in the human liver.
   J Hepatol. 2009.
   PubMed     Related articles    Abstract available
   
   
   April 2009
3. COOPER C , Lawitz EJ, Ghali P, Rodriguez-Torres M, et al
   Evaluation of VCH-759 monotherapy in hepatitis C infection.
   J Hepatol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
4. WEGERT M , Monica NL, Tripodi M, Adler G, et al
   Impaired interferon type I signalling in the liver modulates the hepatic acute phase response in hepatitis C virus transgenic mice.
   J Hepatol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
5. ZHANG YL , Guo YJ, Bin Li, Sun SH, et al
   Hepatitis C virus single-stranded RNA induces innate immunity via Toll-like receptor 7.
   J Hepatol. 2009.
   PubMed     Related articles    Abstract available
   
   
   March 2009
6. FERRI S , Muratori L, Quarneti C, Muratori P, et al
   Clinical features and effect of antiviral therapy on anti-liver/kindey microsomal antibody type 1 positive chronic hepatitis C.
   J Hepatol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
7. RAIMONDI S , Bruno S, Mondelli MU, Maisonneuve P, et al
   Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis.
   J Hepatol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
8. DE VOS R , Verslype C, Depla E, Fevery J, et al
   WITHDRAWN: Ultrastructural visualization of hepatitis C virus components in human and primate liver biopsies.
   J Hepatol. 2009.
   PubMed     Related articles    Abstract available
   
   
   
9. BARTOSCH B
   Hepatitis C virus and its complex interplay with the hepatic glucose and lipid metabolism.
   J Hepatol. 2009.
   PubMed     Related articles   
   
   
   
10. NEGRO F
    Correction of insulin resistance in chronic hepatitis C patients not responding to the standard of care: More questions than answers.
    J Hepatol. 2009.
    PubMed     Related articles   
    
    
    
11. SERFATY L , Fartoux L, Poupon R
    Pioglitazone as adjuvant therapy in chronic hepatitis C: Sequential rather than concomitant administration with pegylated interferon and ribavirin?
    J Hepatol. 2009.
    PubMed     Related articles   
    
    
    
12. NEUMANN AU , Pianko S, Zeuzem S, Yoshida EM, et al
    Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naive patients with genotype 1, chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Related articles    Abstract available
    
    
    February 2009
13. KASAI D , Adachi T, Deng L, Nagano-Fujii M, et al
    HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
    J Hepatol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
14. VLIEGEN I , Paeshuyse J, Burghgraeve TD, Lehman LS, et al
    Substituted imidazopyridines as potent inhibitors of HCV replication.
    J Hepatol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
15. DIONISIO N , Garcia-Mediavilla MV, Sanchez-Campos S, Majano PL, et al
    Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes.
    J Hepatol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
16. KIM KA , Lin W, Tai AW, Shao RX, et al
    Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection.
    J Hepatol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
17. ROCHE B , Samuel D
    Antiviral therapy in HCV-infected cirrhotics awaiting liver transplantation: A costly strategy for mixed virological results.
    J Hepatol. 2009.
    PubMed     Related articles   
    
    
    
18. DAI CY , Huang JF, Hsieh MY, Hou NJ, et al
    Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients.
    J Hepatol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
19. CAMMA C , Petta S
    Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the future.
    J Hepatol. 2009.
    PubMed     Related articles   
    
    
    January 2009
20. SAUTER D , Himmelsbach K, Kriegs M, Yepes MC, et al
    Localization determines function: N-terminally truncated NS5A fragments accumulate in the nucleus and impair HCV replication.
    J Hepatol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
21. WESESLINDTNER L , Neumann-Haefelin C, Viazov S, Haberstroh A, et al
    Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability.
    J Hepatol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
22. KUMADA T , Toyoda H, Kiriyama S, Sone Y, et al
    Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels.
    J Hepatol. 2009.
    PubMed     Related articles    Abstract available
    
    
    
23. BEDOSSA P , Carrat F
    Liver biopsy: the best, not the gold standard.
    J Hepatol. 2009;50:1-3.
    PubMed     Related articles   
    
    
    
24. MEHTA SH , Lau B, Afdhal NH, Thomas DL, et al
    Exceeding the limits of liver histology markers.
    J Hepatol. 2009;50:36-41.
    PubMed     Related articles    Abstract available
    
    
    December 2008
25. CARRION JA , Martinez-Bauer E, Crespo G, Ramirez S, et al
    Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
26. MERCHANTE N , de Los Santos-Gil I, Merino D, Gonzalez-Serrano M, et al
    Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
27. KIM SI , Shin D, Lee H, Ahn BY, et al
    Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
28. PIETSCHMANN T
    Regulation of hepatitis C virus replication by microRNAs.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
29. HUANG JF , Dai CY, Yu ML, Shin SJ, et al
    Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
30. CHOLONGITAS E , Manousou P, Samonakis D, Burroughs AK, et al
    Progression of HCV infection in patients with chronic kidney disease.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
31. MARTIN P , Fabrizi F
    Progression of HCV infection in patients with chronic kidney disease: Reply.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
32. GOZLAN J , Lacombe K, Gault E, Raguin G, et al
    Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
33. BERRES ML , Papen S, Pauels K, Schmitz P, et al
    A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
34. GIANNINI EG , Savarino V
    HCV and fat: Something is missing.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
35. DAI CY , Chuang WL, Ho CK, Yu ML, et al
    Hepatitis C viremia and serum lipid levels: A clue from an epidemiology study.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
36. REDDY KR , Nelson DR, Zeuzem S
    Ribavirin: Current role in the optimal clinical management of chronic hepatitis C.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
37. TAI AW , Chung RT
    Treatment failure in hepatitis C: Mechanisms of non-response.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
38. MICHALAK TI , Pham TN
    Anti-HCV core antibody: A potential new marker of occult and otherwise serologically silent HCV infection.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    November 2008
39. VARCHETTA S , Oliviero B, Francesca Donato M, Agnelli F, et al
    Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
40. MIHM U , Ackermann O, Welsch C, Herrmann E, et al
    Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis C.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
41. WEDEMEYER I , Bechmann LP, Odenthal M, Jochum C, et al
    Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: Therapeutic implications for hepatitis C.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
42. SCHUSTER C , Baumert TF
    EWI-2wint - A host cell factor inhibiting hepatitis C virus entry.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
43. THOMPSON A , Patel K, Tillman H, McHutchison JG, et al
    Directly acting antivirals for the treatment of patients with hepatitis C infection: A clinical development update addressing key future challenges.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
44. QUIROGA JA , Castillo I, Llorente S, Bartolome J, et al
    Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
45. KIM E , Li K, Lieu C, Tong S, et al
    Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis.
    J Hepatol. 2008;49:787-98.
    PubMed     Related articles    Abstract available
    
    
    October 2008
46. EUROPEAN ASSOCIATION FOR THE S
    EASL Clinical Practice Guidelines: Management of chronic hepatitis B.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
47. CASTERA L , Bail BL, Roudot-Thoraval F, Bernard PH, et al
    Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
48. FORNS X
    Role of nosocomial hospital transmission in acute hepatitis C: Reply.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
49. MORIN T , Pariente A, Cadranel JF, Denis J, et al
    Role of nosocomial hospital transmission in acute hepatitis C.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
50. HASSAN MM , Spitz MR, Thomas MB, Curley SA, et al
    The association of family history of liver cancer with hepatocellular carcinoma: A case-control study in the United States.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
51. MACIAS J , Recio E, Vispo E, Rivero A, et al
    Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    September 2008
52. ALBERT ML , Decalf J, Pol S
    Plasmacytoid dendritic cells move down on the list of suspects: In search of the immune pathogenesis of chronic hepatitis C.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
53. TEUBER G , Schafer A, Rimpel J, Paul K, et al
    Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
54. TSAI YH , Kuang WF, Lu TY, Kao JH, et al
    The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
55. GRIFFIN S , Trowbridge R, Thommes P, Parry N, et al
    Chimeric GB virus B genomes containing hepatitis C virus p7 are infectious in vivo.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    August 2008
56. WHITE DL , Ratziu V, El-Serag HB
    Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
57. RAIMONDO G , Saitta C
    Treatment of the hepatitis B virus and hepatitis C virus co-infection: Still a challenge for the hepatologist.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
58. SILVA MO
    Compare trial: updated data.
    J Hepatol. 2008;49:288-9.
    PubMed     Related articles   
    
    
    July 2008
59. KAU A , Vermehren J, Sarrazin C
    Treatment predictors of a sustained virologic response in hepatitis B and C.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
60. PAGGI S , Colli A, Fraquelli M, Vigano M, et al
    A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: A comparison using histology with internal-external validation.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
61. LA MURA V , Renzo AD, Perna F, D'Agostino D, et al
    Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
62. SELZNER N , McGilvray I
    Can genetic variations predict HCV treatment outcomes?
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
63. GARATTINI S
    Is there discrimination in access to therapy for HCV patients?
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
64. SANTANTONIO T , Wiegand J, Tilman Gerlach J
    Acute hepatitis C: Current status and remaining challenges.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
65. PIROTH L , Carrat F, Larrat S, Goderel I, et al
    Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
66. MCPHERSON S , Jonsson JR, Barrie HD, O'Rourke P, et al
    Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
67. GHEORGHE L , Iacob S, Csiki IE
    Prevalence of hepatitis C in Romania: Different from European rates?
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
68. QUER J , Esteban JI, Sauleda S
    Prevalence of hepatitis C in Romania: Different from European rates? Reply.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
69. MURAKAMI Y , Aly HH, Tajima A, Inoue I, et al
    Regulation of the hepatitis C virus genome replication by miR-199a.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
70. TOGASHI H , Hashimoto C, Yokozawa J, Suzuki A, et al
    What can be revealed by extending the sensitivity of HBsAg detection to below the present limit?
    J Hepatol. 2008;49:17-24.
    PubMed     Related articles    Abstract available
    
    
    June 2008
71. RENDINA M , Schena A, Schena FP, Francavilla A, et al
    Acute rejection of non-functional allograft in kidney transplant recipients with hepatitis C treated with peginterferon alpha-2a: Reply.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
72. SPERL J , Petrasek J, Spicak J, Viklicky O, et al
    Acute rejection of non-functional allograft in kidney transplant recipients with hepatitis C treated with peginterferon-alpha2a.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
73. MATTHEWS GV , Grebely J, Dore GJ
    The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure.
    J Hepatol. 2008.
    PubMed     Related articles   
    
    
    
74. MARTIN P , Fabrizi F
    Hepatitis C virus and kidney disease.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
75. HALANGK J , Sarrazin C, Neumann K, Puhl G, et al
    Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
76. BURTON JR JR , Klarquist J, Im K, Smyk-Pearson S, et al
    Prospective analysis of effector and regulatory CD4(+) T cells in chronic HCV patients undergoing combination antiviral therapy.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    
77. FUJITA N , Sugimoto R, Motonishi S, Tomosugi N, et al
    Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
78. CHEN W , Wong T, Tomlinson G, Krahn M, et al
    Prevalence and predictors of obesity among individuals with positive hepatitis C antibody in a tertiary referral clinic.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
79. MORGAN TR , Lambrecht RW, Bonkovsky HL, Chung RT, et al
    DNA polymorphisms and response to treatment in patients with chronic hepatitis C: Results from the HALT-C trial.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
80. LETTMEIER B , Muhlberger N, Schwarzer R, Sroczynski G, et al
    Market uptake of new antiviral drugs for the treatment of hepatitis C.
    J Hepatol. 2008.
    PubMed     Related articles    Abstract available
    
    
    May 2008
81. RIBES J , Cleries R, Esteban L, Moreno V, et al
    The influence of alcohol consumption and hepatitis B and C infections on the risk of liver cancer in Europe.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
82. BURIONI R , Perotti M, Mancini N, Clementi M, et al
    Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
83. OVERBECK K , Genne D, Golay A, Negro F, et al
    Pioglitazone in chronic hepatitis C not responding to pegylated interferon-alpha and ribavirin.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
84. ZEUZEM S
    Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients.
    J Hepatol. 2008;.
    PubMed     Related articles   
    
    
    
85. BERENGUER M
    Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
86. DEUFFIC-BURBAN S , Deltenre P, Louvet A, Canva V, et al
    Impact of viral eradication on mortality related to hepatitis C: A modeling approach in France.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
87. SU X , Yee LJ, Im K, Rhodes SL, et al
    Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
88. LIBRA M , Gloghini A, Malaponte G, Gangemi P, et al
    In gastrointestinal mucosa-associated lymphoid tissue lymphomas t(14;18)-(IgH/Bcl-2) translocation clusters in hepatitis C virus-infected patients.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
89. SHORES NJ , Maida I, Soriano V, Nunez M, et al
    Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
90. CASTERA L , Forns X, Alberti A
    Non-invasive evaluation of liver fibrosis using transient elastography.
    J Hepatol. 2008;48:835-47.
    PubMed     Related articles    Abstract available
    
    
    
91. SEBASTIANI G , Alberti A
    Implementing non-invasive markers for liver fibrosis in clinical practice.
    J Hepatol. 2008;48:880-1.
    PubMed     Related articles   
    
    
    April 2008
92. BERNSMEIER C , Duong FH, Christen V, Pugnale P, et al
    Virus induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
93. POTTHOFF A , Wedemeyer H, Boecher WO, Berg T, et al
    The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
94. LAWITZ E , Rodriguez-Torres M, Muir AJ, Kieffer TL, et al
    Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
95. ANDRE P , Lotteau V
    Hepatitis C virus assembly: When fat makes it easier.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
96. FORTON DM , Hamilton G, Allsop JM, Grover VP, et al
    Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
97. DAI CY , Chuang WL, Ho CK, Hsieh MY, et al
    Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: A community-based study.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
98. BARTH H , Robinet E, Liang TJ, Baumert TF, et al
    Mouse models for the study of HCV infection and virus-host interactions.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
99. PEFFAULT DE LATOUR R , Ribaud P, Robin M, Valla D, et al
    Allogeneic hematopoietic cell transplant in HCV-infected patients.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    March 2008
100. FORNS X , Sanchez-Tapias JM, Bruguera M
     Nosocomial acquisition of the hepatitis C virus.
     J Hepatol. 2008;.
     PubMed     Related articles   
     
     
     
101. PUGNALE P , Herrmann E, Neumann AU, Pawlotsky JM, et al
     Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy.
     J Hepatol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
102. DETERDING K , Wiegand J, Gruner N, Wedemeyer H, et al
     Medical procedures as a risk factor for HCV infection in developed countries: Do we neglect a significant problem in medical care?
     J Hepatol. 2008;.
     PubMed     Related articles   
     
     
     
103. KAPLAN DE , Ikeda F, Li Y, Nakamoto N, et al
     Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis.
     J Hepatol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
104. BROERING R , Wu J, Meng Z, Hilgard P, et al
     Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.
     J Hepatol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     February 2008
105. SELZNER N , Chen L, Borozan I, Edwards A, et al
     Hepatic gene expression and prediction of therapy response in chronic hepatitis C patients.
     J Hepatol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
106. SAMUEL D , Weber R, Stock P, Duclos-Vallee JC, et al
     Are HIV-infected patients candidates for liver transplantation?
     J Hepatol. 2008;.
     PubMed     Related articles   
     
     
     
107. KUROSAKI M , Matsunaga K, Hirayama I, Tanaka T, et al
     The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy.
     J Hepatol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
108. CACOUB P , Carrat F, Bedossa P, Lambert J, et al
     Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The fibrovic study - ANRS HC02.
     J Hepatol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
109. LEROY V , Zarski JP
     Clinical applicability of non-invasive markers for liver fibrosis in chronic hepatitis C.
     J Hepatol. 2008;.
     PubMed     Related articles   
     
     
     
110. RODRIGUEZ-TORRES M , Govindarajan S, Sola R, Clumeck N, et al
     Hepatic steatosis in HCV/HIV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study.
     J Hepatol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     January 2008
111. NEWELL P , Villanueva A, Friedman SL, Koike K, et al
     Experimental models of hepatocellular carcinoma.
     J Hepatol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
112. URBANI S , Amadei B, Tola D, Pedrazzi G, et al
     Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: Effect of viremia levels and antiviral treatment.
     J Hepatol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
113. MALLAT A , Hezode C, Lotersztajn S
     Environmental factors as disease accelerators during chronic hepatitis C.
     J Hepatol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
114. ROMERO-GOMEZ M , Fernandez-Rodriguez CM, Andrade RJ, Diago M, et al
     Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C.
     J Hepatol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
115. POPOV Y , Patsenker E, Stickel F, Zaks J, et al
     Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
     J Hepatol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     December 2007
116. VALENTI L , Dongiovanni P, Fargion S, Fracanzani AL, et al
     Iron genes, dysmetabolism and fibrosis in chronic hepatitis C.
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
117. LUPBERGER J , Brino L, Baumert TF
     RNAi - A powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
118. EL-SERAG H , Kramer JR
     Hepatitis C infection: Dying with or from the infection?
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
119. SULKOWSKI MS
     Viral hepatitis and HIV coinfection.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
120. VIDALI M , Tripodi MF, Ivaldi A, Zampino R, et al
     Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
121. SCHOLTES C , Diaz O, Icard V, Kaul A, et al
     Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     November 2007
122. WASMUTH HE , Zaldivar MM, Berres ML, Werth A, et al
     The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
123. MARCELLIN P , Pequignot F, Delarocque-Astagneau E, Zarski JP, et al
     Mortality related to chronic hepatitis B and chronic hepatitis C in France: Evidence for the role of HIV coinfection and alcohol consumption.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
124. SCOTTA C , Garbuglia AR, Ruggeri L, Spada E, et al
     Influence of specific CD4+ T cells and antibodies on evolution of hypervariable region 1 during acute HCV infection.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
125. SZABO G , Dolganiuc A
     Hepatitis C core protein - The "core" of immune deception?
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
126. SULKOWSKI M
     Treatment of hepatitis C in HIV-infected persons: A work in progress.
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
127. ALTER MJ
     Healthcare should not be a vehicle for transmission of hepatitis C virus.
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
128. ESTEBAN JI , Sauleda S, Quer J
     The changing epidemiology of hepatitis C virus infection in Europe.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     October 2007
129. SCHMITZ KJ , Wohlschlaeger J, Lang H, Sotiropoulos GC, et al
     Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
130. TOYODA H , Kumada T, Kaneoka Y, Murakami Y, et al
     Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
131. ZIMMERMANN M , Flechsig C, Monica NL, Tripodi M, et al
     Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
132. MARTI NEZ-BAUER E , Forns X, Armelles M, Planas R, et al
     Hospital admission is a relevant source of hepatitis C virus acquisition in Spain.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
133. BROWN RS JR
     Steroids in recurrent hepatitis C following liver transplantation: Pitfall or panacea?
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
134. CACOUB P , Halfon P, Rosenthal E, Pialoux G, et al
     Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": Modifications in two large surveys between 2004 and 2006.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
135. POUSTCHI H , Negro F, Hui J, Cua IH, et al
     Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     September 2007
136. VIVARELLI M , Burra P, Barba GL, Canova D, et al
     Influence of steroids on HCV recurrence after liver transplantation: A prospective study.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
137. DAL PERO F , Di Maira G, Marin O, Bortoletto G, et al
     Heterogeneity of CK2 phosphorylation sites in the NS5A protein of different hepatitis C virus genotypes.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     July 2007
138. RAJENDRA A , Wong JB
     Economics of chronic hepatitis B and hepatitis C.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
139. MARCELLIN P , Heathcote EJ, Craxi A
     Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the 'accordion' regimen?
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
140. JENSEN GS , Trotter JF
     Treatment of chronic HCV in advanced liver disease: Unmet challenges, reason for optimism.
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
141. WATANABE T , Umehara T, Yasui F, Nakagawa SI, et al
     Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
142. MELUM E , Friman S, Bjoro K, Rasmussen A, et al
     Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
143. BRAU N , Fox RK, Xiao P, Marks K, et al
     Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.-Canadian multicenter study.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     June 2007
144. DI MARCO V , Almasio PL, Ferraro D, Calvaruso V, et al
     Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: A randomized controlled trial.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
145. MARCELLIN P , Horsmans Y, Nevens F, Grange JD, et al
     Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
146. VELDT BJ , van der Vliet HJ, von Blomberg BM, van Vlierberghe H, et al
     Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     May 2007
147. SCHULTHEISS M , Thimme R
     Toll like receptor 7 and hepatitis C virus infection.
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
148. LARRUBIA JR , Calvino M, Benito S, Sanz-de-Villalobos E, et al
     The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
149. AHLENSTIEL G , Nischalke HD, Bueren K, Berg T, et al
     The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
150. POCKROS PJ , Guyader D, Patton H, Tong MJ, et al
     Oral resiquimod in chronic HCV infection: Safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies>
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
151. BURROUGHS AK , Cholongitas E
     Non-invasive tests for liver fibrosis: encouraging or discouraging results?
     J Hepatol. 2007;46:751-5.
     PubMed     Related articles   
     
     
     April 2007
152. RYDER SD
     Outcome of hepatitis C infection: Bleak or benign?
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
153. BENHAMOU Y
     Anemia and clinical outcomes in hepatitis C.
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
154. SOUVIGNET C , Maynard M, Gagnieu MC, Trepo C, et al
     Ribavirin in combination therapy for HCV chronic infection in HIV patients: How to win the war after winning the first battle?
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
155. WARD SM , Fox BC, Brown PJ, Worthington J, et al
     Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
156. LAI WK , Curbishley SM, Goddard S, Alabrabra E, et al
     Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
157. SCHOTT E , Witt H, Neumann K, Taube S, et al
     A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
158. GLUUD C , Brok J, Gong Y, Koretz RL, et al
     Hepatology may have problems with putative surrogate outcome measures.
     J Hepatol. 2007;46:734-42.
     PubMed     Related articles    Abstract available
     
     
     
159. BUENDIA MA
     Tumor suppressors in hepatocellular carcinoma: many are called, but few are chosen.
     J Hepatol. 2007;46:546-8.
     PubMed     Related articles   
     
     
     March 2007
160. CLEMENT S , Negro F
     Hepatitis C virus: The viral way to fatty liver.
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
161. SAMUEL D , Roche B
     Ribavirin in the treatment of recurrent hepatitis C after liver transplantation: Difficult to manage but essential for success.
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
162. GISH RG , Arora S, Reddy KR, Nelson DR, et al
     Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: A randomized, phase 2 study.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     February 2007
163. DAHARI H , Markatou M, Zeremski M, Haller I, et al
     Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
164. BOSETTI C , Levi F, Lucchini F, Zatonski WA, et al
     Worldwide mortality from cirrhosis: An update to 2002.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
165. TARGHER G , Bertolini L, Padovani R, Rodella S, et al
     Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     January 2007
166. REHERMANN B , Naoumov NV
     Immunological techniques in viral hepatitis.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
167. KUO A , Terrault NA
     Antiviral therapy in liver transplant recipients: Is SVR the only endpoint that matters?
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     November 2006
168. KREMER-TAL S , Narla G, Chen Y, Hod E, et al
     Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: